Abstract
Optimization studies on mucoadhesive microspheres of felodipine for nasal delivery were aimed to modulate drug release, enhance residence time of microspheres and thereby improve the therapeutic efficacy of the drug undergoing extensive first pass metabolism. Mucoadhesive sodium alginate microspheres containing felodipine were prepared by emulsion-cross linking method. A 23 factorial design was employed for preparation of microspheres wherein the concentration of polymer, concentration of calcium chloride and cross-linking time were chosen as independent variables while particle size, % mucoadhesion and % drug permeation were taken as dependent variables. Amongst the cross-linking agents screened, calcium chloride was selected on the basis of particle size, regular shape and percentage yield. The microspheres, formulation F3 with least particle size of 39.9 µm, maximum in vitro mucoadhesion 79.98% and % drug permeation 94.8% were adjudged as optimized formulation. The experimental design was validated by extra design check point. SEM revealed the morphological characteristic of microspheres. DSC and XRD confirmed molecular dispersion of the drug in the microspheres polymeric matrix. DRS revealed no chemical interaction between the drug and polymer used. Histological study asserted no damage to the sheep nasal mucosal structure when incubated with F3. The formulation was found to be stable for a period of 3 months.
Keywords: Felodipine, mucoadhesive microspheres, factorial design, in vitro permeation, histological analysis.
Drug Delivery Letters
Title:Cross-linked Mucoadhesive Microspheres based on Anionic Heteropolysaccharide for Nasal Delivery of Felodipine: Optimization and in vitro Evaluation
Volume: 3 Issue: 2
Author(s): Shobhita Mishra, Niraj Singh Patel, Manish Kumar and Kamla Pathak
Affiliation:
Keywords: Felodipine, mucoadhesive microspheres, factorial design, in vitro permeation, histological analysis.
Abstract: Optimization studies on mucoadhesive microspheres of felodipine for nasal delivery were aimed to modulate drug release, enhance residence time of microspheres and thereby improve the therapeutic efficacy of the drug undergoing extensive first pass metabolism. Mucoadhesive sodium alginate microspheres containing felodipine were prepared by emulsion-cross linking method. A 23 factorial design was employed for preparation of microspheres wherein the concentration of polymer, concentration of calcium chloride and cross-linking time were chosen as independent variables while particle size, % mucoadhesion and % drug permeation were taken as dependent variables. Amongst the cross-linking agents screened, calcium chloride was selected on the basis of particle size, regular shape and percentage yield. The microspheres, formulation F3 with least particle size of 39.9 µm, maximum in vitro mucoadhesion 79.98% and % drug permeation 94.8% were adjudged as optimized formulation. The experimental design was validated by extra design check point. SEM revealed the morphological characteristic of microspheres. DSC and XRD confirmed molecular dispersion of the drug in the microspheres polymeric matrix. DRS revealed no chemical interaction between the drug and polymer used. Histological study asserted no damage to the sheep nasal mucosal structure when incubated with F3. The formulation was found to be stable for a period of 3 months.
Export Options
About this article
Cite this article as:
Mishra Shobhita, Patel Singh Niraj, Kumar Manish and Pathak Kamla, Cross-linked Mucoadhesive Microspheres based on Anionic Heteropolysaccharide for Nasal Delivery of Felodipine: Optimization and in vitro Evaluation, Drug Delivery Letters 2013; 3 (2) . https://dx.doi.org/10.2174/2210303111303020006
DOI https://dx.doi.org/10.2174/2210303111303020006 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Statins for Early Stage Chronic Kidney Disease: An Overview of Reviews
Cardiovascular & Hematological Disorders-Drug Targets Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Molecular Mechanisms, Emerging Etiological Insights and Models to Test Potential Therapeutic Interventions in Alzheimers Disease
Current Alzheimer Research Quality of Life in Individuals with Diabetic Foot Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Therapeutic Agents for Resistant Gram-Positive Infections
Current Drug Therapy Stem Cell Based Tissue Engineering and Regenerative Medicine: A Review Focusing on Adult Stem Cells
Current Tissue Engineering (Discontinued) Diabetogenic Effects of Parthinium hysterophorous Induced Allergic Rhinitis
Inflammation & Allergy - Drug Targets (Discontinued) HIV-Therapy Associated Lipodystrophy: Experimental and Clinical Evidence for the Pathogenesis and Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets Impact of Sex Hormone Metabolism on the Vascular Effects of Menopausal Hormone Therapy in Cardiovascular Disease
Current Drug Metabolism Proinflammatory Activities of Leptin in Non-Autoimmune Conditions
Inflammation & Allergy - Drug Targets (Discontinued) Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
Current Drug Targets - Cardiovascular & Hematological Disorders Phytochemicals from Peanut (<i>Arachis hypogaea</i> L.) Skin Extract with Potential for Pharmacological Activity
Current Bioactive Compounds Estrogen Receptor 1 Agonist PPT Stimulates Slc2a4 Gene Expression and Improves Insulin-Induced Glucose Uptake in Adipocytes
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Protein Modification by β-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Personality and Genetics
Current Psychiatry Reviews Obesity and Metabolic Syndrome Affect the Cholinergic Transmission a nd Cognitive Functions
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: New Therapeutic Targets in Clinical Medicine)
Current Pharmaceutical Design